{"version":"1.0","type":"link","title":"Exposure-response relationship of nivolumab and ipilimumab in patients with metastatic renal cell carcinoma from the randomised phase 2 BIONIKK study.","author_name":"Blanchet B 외","author_url":"https://prs-insight.online/author/Blanchet%20B","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/167276","thumbnail_width":1200,"thumbnail_height":630}